Ecofibre Limited (EOFBY)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ecofibre Limited (EOFBY) trades at $0.84 with AI Score 40/100 (Grade C). Ecofibre Limited is an Australian-based company focused on breeding, growing, manufacturing, and selling hemp products. Market cap: $73.67M, Sector: Healthcare.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for EOFBY: EOFBY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates EOFBY against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
EOFBY: 1/1 perspectives are bearish.
How is this calculated? →Ecofibre Limited (EOFBY) Healthcare & Pipeline Overview
Ecofibre Limited is an Australian hemp company operating in the healthcare sector, focusing on CBD products, hemp-based foods, and textiles. With a negative profit margin and trading as an ADR on the OTC market, Ecofibre faces challenges in a competitive landscape against companies like BIOGF and CKMTF.
What Is the Investment Thesis for EOFBY?
Investing in Ecofibre Limited (EOFBY) presents a speculative opportunity due to its presence in the emerging hemp and CBD market. However, the company's negative profit margin of -158.5% and negative gross margin of -3.9% raise concerns about its financial sustainability. The company's beta of 1.54 suggests higher volatility compared to the market. Growth catalysts include expansion of its product lines and increased market penetration in the US and Australia. The investment thesis hinges on Ecofibre's ability to achieve profitability and effectively compete in a crowded market. Investors should carefully consider the risks associated with investing in an OTC-traded ADR with limited financial disclosure.
Based on FMP financials and quantitative analysis
EOFBY Key Highlights
- Market capitalization of $73.67M indicates a small-cap company.
- Negative P/E ratio of -0.16 reflects current losses and lack of profitability.
- Profit margin of -158.5% signals significant operational inefficiencies or high costs.
- Gross margin of -3.9% suggests challenges in managing the cost of goods sold.
- Beta of 1.54 indicates higher volatility compared to the overall market.
Who Are EOFBY's Competitors?
EOFBY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BIOGF Biocartis Group N.V. | $0.66 | -85.33% | $65.41M | 52 |
| CKMTF Carmat S.A. | $12.75 | -50.96% | $85.19M | 61 |
| EEOIF Elegance Optical International Holdings Limited | $0.07 | +0.00% | $63.38M | 46 |
| ETXPF E-therapeutics Plc | $0.13 | +0.00% | $75.96M | 38 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.05M | 64 |
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are EOFBY's Key Strengths?
- Vertically integrated operations.
- Proprietary hemp genetics.
- Established brand in Australia.
- Diverse product portfolio.
What Are EOFBY's Weaknesses?
- Negative profit margin.
- Limited market presence in the United States.
- Reliance on the hemp and CBD market.
- OTC listing indicates higher risk.
What Could Drive EOFBY Stock Higher?
- Potential regulatory changes in the US regarding CBD products could open new market opportunities.
- Increasing consumer awareness and acceptance of CBD and hemp-based products.
- Expansion of distribution channels and partnerships with major retailers.
What Are the Key Risks for EOFBY?
- Financial-distress signal — its Altman Z-Score of -1.38 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-77.4%) — the business is not currently generating profit on shareholder capital.
- Regulatory uncertainty and evolving legal landscape for hemp and CBD products.
- Intense competition in the hemp and CBD market.
- Negative profit and gross margins raise concerns about financial sustainability.
- Fluctuations in hemp prices and agricultural risks.
What Are the Growth Opportunities for EOFBY?
- Expansion of Ananda Health Product Line: Ecofibre has the opportunity to expand its Ananda Health segment by introducing new CBD-based products targeting specific health conditions. The global CBD market is projected to reach $55.79 billion by 2028, growing at a CAGR of 25.9% from 2021. This expansion could include developing formulations for sleep, anxiety, and pain management, leveraging the growing consumer interest in natural health solutions. Success hinges on rigorous testing, regulatory compliance, and effective marketing.
- Increased Market Penetration in the United States: Ecofibre can increase its market share in the United States by expanding its distribution network and marketing efforts. The US is the largest CBD market globally, with significant growth potential. This could involve partnerships with major retailers, online marketplaces, and healthcare providers. Effective branding and consumer education are crucial for success in this competitive market. The timeline for significant market penetration is estimated at 2-3 years.
- Development of Hemp-Based Industrial Products: Ecofibre has the potential to capitalize on the growing demand for sustainable and eco-friendly materials by developing hemp-based industrial products. This includes textiles, building materials, and bioplastics. The global market for industrial hemp is projected to reach $15.2 billion by 2027. Ecofibre can leverage its expertise in hemp cultivation and processing to create innovative and competitive products. Research and development, strategic partnerships, and government support are essential for success.
- Expansion of Ananda Food Segment: Ecofibre can expand its Ananda Food segment by introducing new hemp-based food products and increasing its distribution channels. The global hemp food market is experiencing significant growth, driven by increasing consumer awareness of the nutritional benefits of hemp seeds and protein. This expansion could include developing hemp-based snacks, beverages, and ingredients for food manufacturers. Effective marketing and product innovation are crucial for success.
- Strategic Partnerships and Acquisitions: Ecofibre can pursue strategic partnerships and acquisitions to expand its product portfolio, market reach, and technological capabilities. This could involve partnering with other hemp companies, pharmaceutical companies, or technology providers. Acquisitions can provide access to new markets, technologies, and intellectual property. Careful due diligence and integration are essential for successful partnerships and acquisitions.
What Opportunities Does EOFBY Have?
- Expansion into new markets.
- Development of new hemp-based products.
- Strategic partnerships and acquisitions.
- Increasing consumer demand for CBD products.
What Threats Does EOFBY Face?
- Regulatory uncertainty in the hemp and CBD market.
- Intense competition.
- Fluctuations in hemp prices.
- Potential changes in consumer preferences.
What Are EOFBY's Competitive Advantages?
- Vertically integrated operations providing control over the supply chain.
- Proprietary hemp genetics and cultivation techniques.
- Established brand recognition in the Australian market.
- Expertise in hemp processing and product development.
What Does EOFBY Do?
Ecofibre Limited, established in 2009 and headquartered in Sydney, Australia, is a vertically integrated hemp company. It cultivates, manufactures, and markets a diverse range of hemp-derived products across the United States and Australia. The company operates through three primary segments: Ananda Health, Ananda Food, and Hemp Black. Ananda Health focuses on CBD products for human and pet consumption, including oils, capsules, and topical creams. Ananda Food offers hemp-related food products such as hemp seeds, protein powders, and snacks. Hemp Black develops and markets textile and hemp-based industrial products. Ecofibre's business model encompasses the entire hemp value chain, from seed to sale, allowing for quality control and product innovation. The company aims to capitalize on the growing demand for hemp-derived products in the health, wellness, and industrial sectors. However, it faces competition from established players in the CBD and hemp industries, requiring continuous innovation and effective marketing strategies to maintain and grow its market share. Ecofibre's products are available through various channels, including online retail, brick-and-mortar stores, and partnerships with healthcare professionals.
What Products and Services Does EOFBY Offer?
- Breeds and grows hemp plants.
- Manufactures CBD products for human consumption.
- Manufactures CBD products for pet consumption.
- Produces topical health and beauty products.
- Creates hemp-related food products.
- Develops textile and hemp products.
How Does EOFBY Make Money?
- Vertically integrated hemp production from seed to sale.
- Manufacturing and distribution of CBD products.
- Sales of hemp-based food and textile products.
What Industry Does EOFBY Operate In?
Ecofibre Limited operates within the rapidly evolving hemp and CBD industry. The market is characterized by increasing consumer demand for hemp-derived products, driven by perceived health and wellness benefits. However, the industry is also subject to regulatory uncertainty and intense competition. Key players include established CBD brands, pharmaceutical companies, and agricultural businesses. Ecofibre's success depends on its ability to differentiate its products, navigate regulatory hurdles, and establish strong distribution channels. The industry is expected to continue growing, but profitability remains a challenge for many companies due to high operating costs and marketing expenses.
Who Are EOFBY's Key Customers?
- Individuals seeking CBD products for health and wellness.
- Pet owners looking for CBD products for their pets.
- Consumers interested in hemp-based food products.
- Businesses seeking hemp-based textiles and industrial materials.
F-Score 4/9Financial Health
Ecofibre Limited's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -1.38 places it in the distress zone, a signal of elevated financial risk.
ROE -77%Key Financial Metrics
Return on equity for Ecofibre Limited stands at -77.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -62.2%, showing how much profit it generates from its asset base. A current ratio of 1.80 indicates the company holds enough short-term assets to cover its near-term obligations.
Ecofibre Limited (EOFBY) Valuation Context
Valued at $73.67M, EOFBY is classified as a micro-cap stock. Relative to its peer group, EOFBY's quantitative score of 40/100 is below the peer average of 52/100.
EOFBY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Vertically integrated operations.
- Proprietary hemp genetics.
- Established brand in Australia.
- Diverse product portfolio.
Bear Case
- Negative profit margin.
- Limited market presence in the United States.
- Reliance on the hemp and CBD market.
- OTC listing indicates higher risk.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
EOFBY Latest News
No recent news available for EOFBY.
EOFBY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for EOFBY.
Price Targets
Wall Street price target analysis for EOFBY.
EOFBY MoonshotScore
What does this score mean?
The MoonshotScore rates EOFBY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Eric Wang
CEO
Eric Wang serves as the CEO of Ecofibre Limited. Information regarding his detailed career history, education, and previous roles is not available in the provided data. Therefore, a comprehensive background cannot be provided at this time. Further research would be needed to ascertain his specific qualifications and prior experience.
Track Record: Due to the limited information available, a detailed track record of Eric Wang's achievements and strategic decisions at Ecofibre Limited cannot be provided. His tenure length is also unknown. Further research is needed to evaluate his performance and contributions to the company's growth and development.
Ecofibre Limited ADR Information Unsponsored
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. EOFBY is a Level 1 ADR, meaning it trades over-the-counter (OTC) without needing to meet the stricter listing requirements of exchanges like the NYSE or NASDAQ. This allows US investors to invest in Ecofibre Limited more easily.
- Home Market Ticker: Australian Securities Exchange (ASX), Australia
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: EOFB
EOFBY OTC Market Information
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure and may not meet the listing requirements of major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries significant risks due to the lack of regulatory oversight and potential for fraud or manipulation. Companies in this tier may be defunct or experiencing financial difficulties.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Potential for fraud or manipulation.
- Low trading volume and liquidity.
- Higher price volatility.
- Lack of regulatory oversight.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Check for any red flags or warning signs.
- Consult with a financial advisor or investment professional.
- Understand the risks associated with OTC investing.
- Company's history since 2009.
- Operations in both the United States and Australia.
- Presence in the hemp and CBD market.
- Existence of multiple business segments (Ananda Health, Ananda Food, Hemp Black).
Ecofibre Limited Healthcare Stock: Key Questions Answered
What does Ecofibre Limited do?
Ecofibre Limited is a vertically integrated hemp company that cultivates, manufactures, and markets a range of hemp-derived products. These products include CBD oils, capsules, and topical creams under the Ananda Health brand; hemp-based food products under the Ananda Food brand; and textile and industrial products under the Hemp Black brand. The company operates in both the United States and Australia, targeting consumers seeking natural health and wellness solutions, as well as businesses seeking sustainable materials.
What are the main risks for EOFBY?
The main risks for Ecofibre Limited include regulatory uncertainty in the hemp and CBD market, intense competition from established players, and the company's current negative profit and gross margins. Additionally, fluctuations in hemp prices and agricultural risks could impact the company's profitability. As an OTC-traded ADR, EOFBY is also subject to liquidity risk and potential price volatility. Investors should carefully consider these risks before investing.
What are the key factors to evaluate for EOFBY?
Ecofibre Limited (EOFBY) holds an AI score of 40/100 (low). Not financial advice.
How frequently does EOFBY data refresh on this page?
EOFBY prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven EOFBY's recent stock price performance?
Ecofibre Limited (EOFBY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Vertically integrated operations. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider EOFBY overvalued or undervalued right now?
Valuing Ecofibre Limited (EOFBY) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying EOFBY?
Before investing in Ecofibre Limited (EOFBY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding EOFBY to a portfolio?
Key strength of Ecofibre Limited (EOFBY): Vertically integrated operations. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available for CEO background and track record.
- OTC market carries higher risk than major exchanges.
- Financial data based on available information and may not be fully comprehensive.